BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/26/2019 2:56:48 AM | Browse: 640 | Download: 1140
 |
Received |
|
2018-12-03 06:50 |
|
Peer-Review Started |
|
2018-12-03 08:38 |
|
To Make the First Decision |
|
2019-02-18 03:03 |
|
Return for Revision |
|
2019-02-20 00:29 |
|
Revised |
|
2019-03-12 20:57 |
|
Second Decision |
|
2019-03-15 08:43 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2019-03-16 22:57 |
|
Articles in Press |
|
2019-03-16 22:57 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2019-03-21 11:27 |
|
Typeset the Manuscript |
|
2019-08-12 00:57 |
|
Publish the Manuscript Online |
|
2019-08-26 02:56 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Case Report |
| Article Title |
Hepatocellular carcinoma patient was successfully treated with ALPPS and apatinib: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ling Liu, Nian-Feng Li, Qi Zhang and Ling Lin |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Nian-Feng Li, MD, Doctor, Doctor, Department of Hepatobiliary and Pancreatic Surgery, Xiangya Hospital, Central south university, Xiangya Hospital, Central South University, Changsha 410008, Hunan Province, China. dlnf66@163.com |
| Key Words |
Hepatocellular carcinoma; Associating liver partition and portal vein ligation for staged hepatectomy; Apatinib; Case report; ; |
| Core Tip |
Our aim was to explore the feasibility of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) combined with targeted therapy in the treatment of advanced hepatocellular carcinoma (HCC). Herein, we present a case of a 47-year-old male patient with a huge right hepatic mass and an estimated insufficient residual liver, who was successfully treated with ALPPS surgery and apatinib. Postoperative pathology revealed HCC with a significant microvascular embolism. Twenty months later, no tumor reoccurrence was observed, indicating that the combined targeted drug therapy with ALPPS can lead to long-term survival for patients with large HCC. |
| Publish Date |
2019-08-26 02:56 |
| Citation |
Liu L, Li NF, Zhang Q, Lin L. Hepatocellular carcinoma patient was successfully treated with ALPPS and apatinib: A case report. World J Clin Cases 2019; 7(16): 2384-2392 |
| URL |
https://www.wjgnet.com/2307-8960/full/v7/i16/ 2384.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v7.i16.2384 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
